Role of Positron Emission Tomography/Computed Tomography in Preoperative Assessment of Carcinoma Endometrium-a Retrospective Analysis

Overview

Journal Indian J Surg Oncol

Specialty Oncology

Date 2019 Apr 6

PMID 30948905

Citations 3

Authors

Rohini Kulkarni

Rani Akhil Bhat

Vibhawari Dhakharia

Kumar Kallur

Aparna Gangoli

Affiliations

Soon will be listed here.

Abstract

PET/CT has made significant inroads into routine oncological practice in recent times. In our study, we aim to determine its value in preoperative assessment of endometrial carcinoma. A retrospective study between January 2011 and March 2016 was conducted; we included all cases of carcinoma endometrium with a preoperative PET/CT scan. PET/CT images were analyzed and correlated with histological findings after surgical staging. A total of 46 cases were analyzed, mean age was 59.8 years, BMI 30.8 kg/m, and most common histology endometrioid type (69.5%). We correlated PET/CT findings with histopathology as reference standard. PET/CT had a sensitivity of 40%, moderate specificity (75%) and accuracy (71.7%), good NPV (91.2%), but poor PPV (16.7%) for lymph node involvement. A total of 10 (21.7%) cases were detected to have distant metabolically active lesions on PET/CT, seven out of these were positive for malignancy. And 90% of them were either non-endometrioid type or grade two and higher. We found that SUV of primary tumor was significantly higher in patients with deep myometrial invasion ( = 0.018), and high-risk histological type of tumor ( = 0.022), though not statistically significant when lymph nodal involvement ( = 0.9), cervical involvement ( = 0.56), or histological grade ( = 0.84) were considered. Sensitivity and specificity of PET/CT in staging endometrial cancer is not high enough to reliably tailor lymphadenectomy. Although SUV of the primary tumor was significantly higher in patients with deep myometrial invasion and high-risk histological type, it's usefulness in classifying patients into predefined risk groups seems to be limited. However, it is useful in detecting distant metastasis especially in high-grade and non-endometrioid type of tumors. Thus, implementation of PET/CT as a surrogate for surgical staging of endometrial cancer remains enigmatic and is open to further research.

Citing Articles

A Radiomic-Based Machine Learning Model Predicts Endometrial Cancer Recurrence Using Preoperative CT Radiomic Features: A Pilot Study.

Coada C, Santoro M, Zybin V, Di Stanislao M, Paolani G, Modolon C Cancers (Basel). 2023; 15(18).

PMID: 37760503 PMC: 10526953. DOI: 10.3390/cancers15184534.

Application of CT and MRI combined with VEGF-C and EGFR in the identification of endometrial cancer stages.

Li C, Yu J, Fu Z Am J Transl Res. 2021; 13(6):7164-7171.

PMID: 34306477 PMC: 8290686.

ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.

Concin N, Creutzberg C, Vergote I, Cibula D, Mirza M, Marnitz S Virchows Arch. 2021; 478(2):153-190.

PMID: 33604759 DOI: 10.1007/s00428-020-03007-z.

References

Husby J, Reitan B, Biermann M, Trovik J, Bjorge L, Magnussen I . Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients. J Nucl Med. 2015; 56(8):1191-8. DOI: 10.2967/jnumed.115.159913. View

Kitajima K, Suenaga Y, Ueno Y, Maeda T, Ebina Y, Yamada H . Preoperative risk stratification using metabolic parameters of (18)F-FDG PET/CT in patients with endometrial cancer. Eur J Nucl Med Mol Imaging. 2015; 42(8):1268-75. DOI: 10.1007/s00259-015-3037-2. View

Lee H, Ahn B, Hong C, Song B, Kim H, Kang S . Preoperative risk stratification using (18)F-FDG PET/CT in women with endometrial cancer. Nuklearmedizin. 2011; 50(5):204-13. DOI: 10.3413/nukmed-0375-10-12. View

Bollineni V, Ytre-Hauge S, Bollineni-Balabay O, Salvesen H, Haldorsen I . High Diagnostic Value of 18F-FDG PET/CT in Endometrial Cancer: Systematic Review and Meta-Analysis of the Literature. J Nucl Med. 2016; 57(6):879-85. DOI: 10.2967/jnumed.115.170597. View

Petersen H, Holdgaard P, Madsen P, Knudsen L, Gad D, Gravergaard A . FDG PET/CT in cancer: comparison of actual use with literature-based recommendations. Eur J Nucl Med Mol Imaging. 2015; 43(4):695-706. PMC: 4764641. DOI: 10.1007/s00259-015-3217-0. View

Benedetti Panici P, Basile S, Maneschi F, Lissoni A, Signorelli M, Scambia G . Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008; 100(23):1707-16. DOI: 10.1093/jnci/djn397. View

Wu W, Yu M, Su H, Lin K, Lu K, Hwang K . The accuracy of magnetic resonance imaging for preoperative deep myometrium assessment in endometrial cancer. Taiwan J Obstet Gynecol. 2013; 52(2):210-4. DOI: 10.1016/j.tjog.2013.04.010. View

Peungjesada S, Bhosale P, Balachandran A, Iyer R . Magnetic resonance imaging of endometrial carcinoma. J Comput Assist Tomogr. 2009; 33(4):601-8. DOI: 10.1097/RCT.0b013e31818d4279. View

Balasubramaniam G, Sushama S, Rasika B, Mahantshetty U . Hospital-based study of endometrial cancer survival in Mumbai, India. Asian Pac J Cancer Prev. 2013; 14(2):977-80. DOI: 10.7314/apjcp.2013.14.2.977. View

10.

Yahata T, Yagi S, Mabuchi Y, Tanizaki Y, Kobayashi A, Yamamoto M . Prognostic impact of primary tumor SUV on preoperative F-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography in endometrial cancer and uterine carcinosarcoma. Mol Clin Oncol. 2016; 5(4):467-474. PMC: 5038871. DOI: 10.3892/mco.2016.980. View

11.

Kitajima K, Murakami K, Yamasaki E, Kaji Y, Sugimura K . Accuracy of integrated FDG-PET/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer. Eur Radiol. 2009; 19(6):1529-36. DOI: 10.1007/s00330-008-1271-8. View

12.

Colombo N, Carinelli S, Colombo A, Marini C, Rollo D, Sessa C . Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012; 23 Suppl 7:vii27-32. DOI: 10.1093/annonc/mds268. View

13.

Kitchener H, Swart A, Qian Q, Amos C, Parmar M . Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2008; 373(9658):125-36. PMC: 2646126. DOI: 10.1016/S0140-6736(08)61766-3. View

14.

Antonsen S, Jensen L, Loft A, Berthelsen A, Costa J, Tabor A . MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer - a multicenter prospective comparative study. Gynecol Oncol. 2012; 128(2):300-8. DOI: 10.1016/j.ygyno.2012.11.025. View

15.

Kim H, Cho A, Yun M, Kim Y, Kang W . Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer. Ann Nucl Med. 2015; 30(2):104-13. DOI: 10.1007/s12149-015-1037-8. View

16.

Kadkhodayan S, Shahriari S, Treglia G, Yousefi Z, Sadeghi R . Accuracy of 18-F-FDG PET imaging in the follow up of endometrial cancer patients: systematic review and meta-analysis of the literature. Gynecol Oncol. 2012; 128(2):397-404. DOI: 10.1016/j.ygyno.2012.10.022. View

17.

Creasman W . Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet. 2009; 105(2):109. DOI: 10.1016/j.ijgo.2009.02.010. View

18.

Colombo N, Creutzberg C, Amant F, Bosse T, Gonzalez-Martin A, Ledermann J . ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up. Int J Gynecol Cancer. 2015; 26(1):2-30. PMC: 4679344. DOI: 10.1097/IGC.0000000000000609. View

19.

Palma M, Gregianin M, Fiduccia P, Evangelista L, Cervino A, Saladini G . PET/CT imaging in gynecologic malignancies: a critical overview of its clinical impact and our retrospective single center analysis. Crit Rev Oncol Hematol. 2012; 83(1):84-98. DOI: 10.1016/j.critrevonc.2011.10.002. View

20.

Antonsen S, Loft A, Fisker R, Nielsen A, Andersen E, Hogdall E . SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients. Gynecol Oncol. 2013; 129(2):298-303. DOI: 10.1016/j.ygyno.2013.01.019. View